-
1
-
-
77954244738
-
Handheld ultrasound bnatriuretic peptide for screening stage B heart failure
-
Hebert K, Horswell R, Heidenreich P, et al. Handheld ultrasound, Bnatriuretic peptide for screening stage B heart failure. South Med J 2010;103:616Y622
-
(2010)
South Med J
, vol.103
, pp. 661-622
-
-
Hebert, K.1
Horswell, R.2
Heidenreich, P.3
-
2
-
-
58849121949
-
Recommendations for the evaluation of left ventricular diastolic function by echocardiography
-
Nagueh SF, Appleton CP, Gillebert TC. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 2009;22:107Y133
-
(2009)
J Am Soc Echocardiogr
, vol.22
, pp. 107-133
-
-
Nagueh, S.F.1
Appleton, C.P.2
Gillebert, T.C.3
-
3
-
-
34548154055
-
Utility of doppler echocardiography and tissue doppler imaging in the estimation of diastolic function in heart failure with normal ejection fraction: A comparative doppler-conductance catheterization study
-
Kasner M, Westermann D, Steendijk P. Utility of Doppler echocardiography and tissue Doppler imaging in the estimation of diastolic function in heart failure with normal ejection fraction: A comparative Doppler-conductance catheterization study. Circulation 2007;116:637Y647
-
(2007)
Circulation
, vol.116
, pp. 637-647
-
-
Kasner, M.1
Westermann, D.2
Steendijk, P.3
-
4
-
-
33645791709
-
Clinical relevance of biological variation: The lesson of brain natriuretic peptide (BNP) and N terminalproBNP assay
-
Clerico A, Zucchelli C, Pilo G, et al. Clinical relevance of biological variation: The lesson of brain natriuretic peptide (BNP) and N terminalproBNP assay. Clin Chem Lab Med 2006;44:366Y378
-
(2006)
Clin Chem Lab Med
, vol.44
, pp. 366-378
-
-
Clerico, A.1
Zucchelli, C.2
Pilo, G.3
-
5
-
-
0035312862
-
Effects of intravenous brain natriuretic peptide on regional sympathetic activity in patients with chronic heart failure as compared with healthy control subjects
-
Brunner-La Rocca HP, Kaye DM, Woods RL, et al. Effects of intravenous brain natriuretic peptide on regional sympathetic activity in patients with chronic heart failure as compared with healthy control subjects. J Am Coll Cardiol 2001;37:1221Y1227
-
(2001)
J Am Coll Cardiol
, vol.37
, pp. 1221-1227
-
-
Brunner-La Rocca, H.P.1
Kaye, D.M.2
Woods, R.L.3
-
6
-
-
12944329901
-
Cardiac fibrosis in mice lacking brain natriuretic peptide
-
Tamura N, Ogawa Y, Chusho H, et al. Cardiac fibrosis in mice lacking brain natriuretic peptide. Proc Natl Acad Sci U S A 2000;97:4239Y4244
-
(2000)
Proc Natl Acad Sci U S A
, vol.97
, pp. 4239-4244
-
-
Tamura, N.1
Ogawa, Y.2
Chusho, H.3
-
7
-
-
0038503201
-
Heritability and genetic linkage of plasma natriuretic peptide levels
-
Wang TJ, Larson MG, Levy D, et al. Heritability and genetic linkage of plasma natriuretic peptide levels. Circulation 2003;108:13Y16
-
(2003)
Circulation
, vol.108
, pp. 13-16
-
-
Wang, T.J.1
Larson, M.G.2
Levy, D.3
-
8
-
-
0037531814
-
The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population
-
Raymond I, Groenning BA, Hildebrandt PR, et al. The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population. Heart 2003;89:745Y751
-
(2003)
Heart
, vol.89
, pp. 745-751
-
-
Raymond, I.1
Groenning, B.A.2
Hildebrandt, P.R.3
-
9
-
-
0037019567
-
Plasma brain natriuretic peptide concentration: Impact of age and gender
-
Redfield MM, Rodeheffer RJ, Jacobsen SJ. Plasma brain natriuretic peptide concentration: Impact of age and gender. J Am Coll Cardiol 2002; 40: 976Y982
-
(2002)
J Am Coll Cardiol
, vol.40
, pp. 976-982
-
-
Redfield, M.M.1
Rodeheffer, R.J.2
Jacobsen, S.J.3
-
10
-
-
21744431993
-
Left ventricular hypertrophy is more prevalent in blacks than whites in the general population: The Dallas Heart Study
-
Drazner MH, Dries DL, Peshock RM, et al. Left ventricular hypertrophy is more prevalent in blacks than whites in the general population: The Dallas Heart Study. Hypertension 2005;46:124Y129
-
(2005)
Hypertension
, vol.46
, pp. 124-129
-
-
Drazner, M.H.1
Dries, D.L.2
Peshock, R.M.3
-
11
-
-
29344457181
-
B-type natriuretic peptide levels in obese patients with advanced heart failure
-
Horwich, TB, Hamilton MA, Fonarow GC. B-type natriuretic peptide levels in obese patients with advanced heart failure. J Am Coll Cardiol 2006;47:85Y90
-
(2006)
J Am Coll Cardiol
, vol.47
, pp. 85-90
-
-
Horwich, T.B.1
Hamilton, M.A.2
Fonarow, G.C.3
-
12
-
-
7544240941
-
Relationship between obesity and B-type natriuretic peptide levels
-
McCord J, Mundy BJ, Hudson MP, et al. Relationship between obesity and B-type natriuretic peptide levels. Arch Intern Med 2004;164:2247Y2252
-
(2004)
Arch Intern Med
, vol.164
, pp. 2247-2252
-
-
McCord, J.1
Mundy, B.J.2
Hudson, M.P.3
-
13
-
-
0030804506
-
Immunoreactive Amino-terminal Pro-brain Natriuretic Peptide (N Terminal-Pro BNP): A New Marker Of Cardiac Impairment
-
Hunt PJ, Richards AM, Nicholls MG. Immunoreactive amino-terminal pro-brain natriuretic peptide (N terminal-Pro BNP): A new marker of cardiac impairment. Clin Endocrinol (Oxf) 1997;47:287Y296
-
(1997)
Clin Endocrinol (Oxf
, vol.47
, pp. 287-296
-
-
Hunt, P.J.1
Richards, A.M.2
Nicholls, M.G.3
-
14
-
-
84873362046
-
-
San Diego California 92121 Roche Diagnostics Indianapolis IN.
-
Biosite Incorporated 9975 Summers Ridge Road San Diego, California 92121 Roche Diagnostics, Indianapolis, IN 46256-1045
-
Biosite Incorporated 9975 Summers Ridge Road
, pp. 46256-41055
-
-
-
15
-
-
0037130155
-
Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure
-
Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002;347:161Y167
-
(2002)
N Engl J Med
, vol.347
, pp. 161-167
-
-
Maisel, A.S.1
Krishnaswamy, P.2
Nowak, R.M.3
-
16
-
-
30744476790
-
The effects of ejection fraction on n-terminal probnp and bnp levels in patients with acute chf: Analysis from the probnp investigation of dyspnea in the emergency department (pride) study
-
O'Donoghue M, Chen A, Baggish AL, et al. The effects of ejection fraction on N-terminal ProBNP and BNP levels in patients with acute CHF: Analysis from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study. J Card Fail 2005;11(5 Suppl):S9YS14
-
(2005)
J Card Fail
, vol.11
, Issue.5 SUPPL.
-
-
O'Donoghue, M.1
Chen, A.2
Baggish, A.L.3
-
17
-
-
29344452483
-
Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: Results from the probnp investigation of dyspnea in the emergency department (pride) study
-
Anwaruddin S, Lloyd-Jones DM, Baggish A, et al. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: Results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study. J Am Coll Cardiol 2006; 47:91Y97
-
(2006)
J Am Coll Cardiol
, vol.47
, pp. 91-97
-
-
Anwaruddin, S.1
Lloyd-Jones, D.M.2
Baggish, A.3
-
18
-
-
0347539775
-
Plasma B- type natriuretic peptide levels in ambulatory patients with established chronic symptomatic systolic heart failure
-
Tang WH, Girod JP, Lee MJ, et al. Plasma B- type natriuretic peptide levels in ambulatory patients with established chronic symptomatic systolic heart failure. Circulation 2003;108:2964Y2966
-
(2003)
Circulation
, vol.108
, pp. 2964-2966
-
-
Tang, W.H.1
Girod, J.P.2
Lee, M.J.3
-
19
-
-
33646201176
-
N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide for identifying coronary artery disease and left ventricular hypertrophy in ambulatory chronic kidney disease patients
-
Khan IA, Fink J, Nass C, et al. N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide for identifying coronary artery disease and left ventricular hypertrophy in ambulatory chronic kidney disease patients. Am J Cardiol 2006;97:1530Y1534
-
(2006)
Am J Cardiol
, vol.97
, pp. 1530-1534
-
-
Khan, I.A.1
Fink, J.2
Nass, C.3
-
20
-
-
4444311314
-
Diagnostic and prognostic value of plasma brain natriuretic peptide in non-dialysis-dependent CRF
-
Takami Y, Horio T, Iwashima Y, et al. Diagnostic and prognostic value of plasma brain natriuretic peptide in non-dialysis-dependent CRF. Am J Kidney Dis 2004;44:420Y428
-
(2004)
Am J Kidney Dis
, vol.44
, pp. 420-428
-
-
Takami, Y.1
Horio, T.2
Iwashima, Y.3
-
21
-
-
65749113328
-
B-type natriuretic peptidedirected ultrafiltration improves care in acutely hospitalized dialysis patients
-
Tapolyai M, Uysal A, Maeweathers G, et al. B-type natriuretic peptidedirected ultrafiltration improves care in acutely hospitalized dialysis patients. Congest Heart Fail 2009;15:131Y135
-
(2009)
Congest Heart Fail
, vol.15
, pp. 131-135
-
-
Tapolyai, M.1
Uysal, A.2
Maeweathers, G.3
-
22
-
-
77955887643
-
Elevation of B-type natriuretic peptide is a sensitive marker of left ventricular diastolic dysfunction in patients with maintenance haemodialysis
-
Liu H, Zhang YZ, Gao M, et al. Elevation of B-type natriuretic peptide is a sensitive marker of left ventricular diastolic dysfunction in patients with maintenance haemodialysis. Biomarkers 2010;15:533Y537
-
(2010)
Biomarkers
, vol.15
, pp. 533-537
-
-
Liu, H.1
Zhang, Y.Z.2
Gao, M.3
-
23
-
-
12244282481
-
Comparison of plasma levels of mature adrenomedullin and natriuretic peptide as markers of cardiac function in hemodialysis patients with coronary artery disease
-
Osajima A, Okazaki M, Tamura M, et al. Comparison of plasma levels of mature adrenomedullin and natriuretic peptide as markers of cardiac function in hemodialysis patients with coronary artery disease. Nephron 2002;92:832Y839
-
(2002)
Nephron
, vol.92
, pp. 832-839
-
-
Osajima, A.1
Okazaki, M.2
Tamura, M.3
-
24
-
-
34548283601
-
Factors determining extreme brain natriuretic peptide elevation
-
Guglin M, Hourani R, Pitta S. Factors determining extreme brain natriuretic peptide elevation. Congest Heart Fail 2007;13:136Y141
-
(2007)
Congest Heart Fail
, vol.13
, pp. 136-141
-
-
Guglin, M.1
Hourani, R.2
Pitta, S.3
-
25
-
-
2642539999
-
Elimination of the cardiac natriuretic peptides B-type natriuretic peptide (BNP) and N-terminal proBNP by hemodialysis
-
Wahl HG, Graf S, Renz H, et al. Elimination of the cardiac natriuretic peptides B-type natriuretic peptide (BNP) and N-terminal proBNP by hemodialysis. Clin Chem 2004;50:1071Y1074
-
(2004)
Clin Chem
, vol.50
, pp. 1071-1074
-
-
Wahl, H.G.1
Graf, S.2
Renz, H.3
-
26
-
-
58149332678
-
Blood B-type natriuretic peptide and dialysis: Present assessment and future analyses
-
Flemmer M, Rajab H, Mathena T, et al. Blood B-type natriuretic peptide and dialysis: Present assessment and future analyses. South Med J 2008;101:1094Y1100
-
(2008)
South Med J
, vol.101
, pp. 1094-1100
-
-
Flemmer, M.1
Rajab, H.2
Mathena, T.3
-
27
-
-
33646024635
-
Usefulness of bedside testing for brain natriuretic peptide to identify right ventricular dysfunction and outcome in normotensive patients with acute pulmonary embolism
-
Pieralli F, Olivotto I, Vanni S, et al. Usefulness of bedside testing for brain natriuretic peptide to identify right ventricular dysfunction and outcome in normotensive patients with acute pulmonary embolism. Am J Cardiol 2006;97:1386Y1390
-
(2006)
Am J Cardiol
, vol.97
, pp. 1386-1390
-
-
Pieralli, F.1
Olivotto, I.2
Vanni, S.3
-
28
-
-
70349678990
-
Natriuretic peptides and troponins in pulmonary embolism: A meta-analysis
-
Lega JC, Lacasse Y, Lakhal L, et al. Natriuretic peptides and troponins in pulmonary embolism: A meta-analysis. Thorax 2009;64:869Y875
-
(2009)
Thorax
, vol.64
, pp. 869-875
-
-
Lega, J.C.1
Lacasse, Y.2
Lakhal, L.3
-
29
-
-
78650597824
-
Comparison of biomarkers for predicting disease severity and long-term respiratory prognosis in patients with acute pulmonary embolism
-
Ohigashi H, Haraguchi G, Yoshikawa S, et al. Comparison of biomarkers for predicting disease severity and long-term respiratory prognosis in patients with acute pulmonary embolism. Int Heart J 2010;51:416Y420
-
(2010)
Int Heart J
, vol.51
, pp. 416-420
-
-
Ohigashi, H.1
Haraguchi, G.2
Yoshikawa, S.3
-
30
-
-
26044462594
-
Biomarker-based risk assessment model in acute pulmonary embolism
-
Kostrubiec M, Pruszczyk P, Bochowicz A, et al. Biomarker-based risk assessment model in acute pulmonary embolism. Eur Heart J 2005; 26:2166Y2172
-
(2005)
Eur Heart J
, vol.26
, pp. 2166-2172
-
-
Kostrubiec, M.1
Pruszczyk, P.2
Bochowicz, A.3
-
31
-
-
79951704125
-
The biomarker N-terminal pro-brain natriuretic peptide and liver diseases
-
Wang L, Geng J, Li T, et al. The biomarker N-terminal pro-brain natriuretic peptide and liver diseases. Clin Invest Med 2011;34:E30YE37
-
(2011)
Clin Invest Med
, vol.34
-
-
Wang, L.1
Geng, J.2
Li, T.3
-
32
-
-
77957157909
-
B-type natriuretic peptide is related to cardiac function and prognosis in hospitalized patients with decompensated cirrhosis
-
Pimenta J, Paulo C, Gomes A, et al. B-type natriuretic peptide is related to cardiac function and prognosis in hospitalized patients with decompensated cirrhosis. Liver Int 2010;30:1059Y1066
-
(2010)
Liver Int
, vol.30
, pp. 1059-1066
-
-
Pimenta, J.1
Paulo, C.2
Gomes, A.3
-
34
-
-
79551551959
-
High circulating N-terminal pro-B-type natriuretic peptide is associated with greater systolic cardiac dysfunction and nonresponsiveness to fluids in septic vs nonseptic critically ill patients
-
Hartemink KJ, Twisk JW, Groeneveld AB. High circulating N-terminal pro-B-type natriuretic peptide is associated with greater systolic cardiac dysfunction and nonresponsiveness to fluids in septic vs nonseptic critically ill patients. J Crit Care 2011;26:108.e1Y8
-
(2011)
J Crit Care
, vol.26
, Issue.108
-
-
Hartemink, K.J.1
Twisk, J.W.2
Groeneveld, A.B.3
-
35
-
-
77949491431
-
Correlation of N terminalproBNP with diastolic left ventricular function in elderly patients with ischemic stroke
-
Ambrosi P, Singeorzan S, Oddoze C, et al. Correlation of N terminalproBNP with diastolic left ventricular function in elderly patients with ischemic stroke. Int J Cardiol 2010;140:126Y128
-
(2010)
Int J Cardiol
, vol.140
, pp. 126-128
-
-
Ambrosi, P.1
Singeorzan, S.2
Oddoze, C.3
-
36
-
-
51849090607
-
Amino-terminal fragment of the prohormone brain-type natriuretic peptide in rheumatoid arthritis
-
Solus J, Chung CP, Oeser A, et al. Amino-terminal fragment of the prohormone brain-type natriuretic peptide in rheumatoid arthritis. Arthritis Rheum 2008;58:2662Y2669
-
(2008)
Arthritis Rheum
, vol.58
, pp. 2662-2669
-
-
Solus, J.1
Chung, C.P.2
Oeser, A.3
-
37
-
-
84555187614
-
Plasma levels of N terminalpro- brain natriuretic peptide in patients with overt and subclinical hyperthyroidism and hypothyroidism
-
Pakuaa D, Marek B, Kajdaniuk D, et al. Plasma levels of N terminalpro- brain natriuretic peptide in patients with overt and subclinical hyperthyroidism and hypothyroidism. Endokrynol Pol 2011;62:523Y528
-
(2011)
Endokrynol Pol
, vol.62
, pp. 523-528
-
-
Pakuaa, D.1
Marek, B.2
Kajdaniuk, D.3
-
38
-
-
77952566473
-
N-terminal pro-brain natriuretic peptide and tumor necrosis factor-alpha both are increased in patients with hepatitis C
-
Antonelli A, Ferri C, Ferrari SM, et al. N-terminal pro-brain natriuretic peptide and tumor necrosis factor-alpha both are increased in patients with hepatitis C. J Interferon Cytokine Res 2010;30:359Y363
-
(2010)
J Interferon Cytokine Res
, vol.30
, pp. 359-363
-
-
Antonelli, A.1
Ferri, C.2
Ferrari, S.M.3
-
39
-
-
84857361007
-
Elevation of B-type natriuretic peptide level in asymptomatic hepatitis B virus-positive patients is not associated with abnormalities of cardiac function
-
Kucukazman M, Ata N, Yavuz B, et al. Elevation of B-type natriuretic peptide level in asymptomatic hepatitis B virus-positive patients is not associated with abnormalities of cardiac function. Med Princ Pract 2012; 21:150Y155
-
(2012)
Med Princ Pract
, vol.21
, pp. 150-155
-
-
Kucukazman, M.1
Ata, N.2
Yavuz, B.3
-
40
-
-
1242295182
-
Predischarge B- type natriuretic peptide after decompensated heart failure
-
Logeart D, Thabut G, Jourdain P. Predischarge B- type natriuretic peptide after decompensated heart failure. J Am Coll Cardiol 2004;43:635Y641
-
(2004)
J Am Coll Cardiol
, vol.43
, pp. 635-641
-
-
Logeart, D.1
Thabut, G.2
Jourdain, P.3
-
41
-
-
0034332845
-
High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure
-
Maeda K, Tsutamoto T, Wada A. High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure. J Am Coll Cardiol 2000;36:1587Y1593
-
(2000)
J Am Coll Cardiol
, vol.36
, pp. 1587-1593
-
-
Maeda, K.1
Tsutamoto, T.2
Wada, A.3
-
42
-
-
66649103645
-
N terminal-pro-BNP is an independent predictor of mortality in patients with end-stage renal disease
-
Svensson M, Gorst-Rasmussen A, Schmidt EB. N terminal-pro-BNP is an independent predictor of mortality in patients with end-stage renal disease. Clin Nephrol 2009;7:380Y386
-
(2009)
Clin Nephrol
, vol.7
, pp. 380-386
-
-
Svensson, M.1
Gorst-Rasmussen, A.2
Schmidt, E.B.3
-
43
-
-
31644431678
-
B-type natriuretic peptide and the risk of cardiovascular events and death in patients with stable angina: Results from the AtheroGene study
-
Schnabel R, Lubos E, Rupprecht HJ, et al. B-type natriuretic peptide and the risk of cardiovascular events and death in patients with stable angina: Results from the AtheroGene study. J Am Coll Cardiol 2006;47:552Y558
-
(2006)
J Am Coll Cardiol
, vol.47
, pp. 552-558
-
-
Schnabel, R.1
Lubos, E.2
Rupprecht, H.J.3
-
44
-
-
70349509236
-
Plasma brain natriuretic peptide as an independent predictor of in-hospital mortality after acute ischemic stroke
-
Shibazaki K, Kimura K, Okada Y, et al. Plasma brain natriuretic peptide as an independent predictor of in-hospital mortality after acute ischemic stroke. Intern Med 2009;48:1601Y1606
-
(2009)
Intern Med
, vol.48
, pp. 1601-1606
-
-
Shibazaki, K.1
Kimura, K.2
Okada, Y.3
-
45
-
-
28944439267
-
Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery disease
-
Morrow DA, de Lemos JA, Blazing MA, et al. Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery disease. JAMA 2005;294:2866Y2871
-
(2005)
JAMA
, vol.294
, pp. 2866-2871
-
-
Morrow, D.A.1
De Lemos, J.A.2
Blazing, M.A.3
-
46
-
-
1442290043
-
Plasma natriuretic peptide levels and the risk of cardiovascular events and death
-
Wang TJ, Larson MG, Levy D, et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 2004; 350:655Y663
-
(2004)
N Engl J Med
, vol.350
, pp. 655-663
-
-
Wang, T.J.1
Larson, M.G.2
Levy, D.3
-
47
-
-
15944419583
-
N-terminal pro-brain natriuretic peptide c-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults
-
Kistorp C, Raymond I, Pedersen F, et al. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults. JAMA 2005; 293:1609Y1616
-
(2005)
JAMA
, vol.293
, pp. 1609-1616
-
-
Kistorp, C.1
Raymond, I.2
Pedersen, F.3
-
48
-
-
0030481630
-
Hemodynamic and renal excretory effects of human brain natriuretic peptide infusion in patients with congestive heart failure A double-blind, placebo-controlled, randomized crossover trial
-
Marcus LS, Hart D, Packer M, et al. Hemodynamic and renal excretory effects of human brain natriuretic peptide infusion in patients with congestive heart failure. A double-blind, placebo-controlled, randomized crossover trial. Circulation 1996;94:3184Y3189
-
(1996)
Circulation
, vol.94
, pp. 3184-3189
-
-
Marcus, L.S.1
Hart, D.2
Packer, M.3
-
49
-
-
0034721244
-
Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure
-
Nesiritide Study Group
-
Colucci WS, Elkayam U, Horton DP, et al. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group. N Engl J Med 2000;343:246Y253
-
(2000)
N Engl J Med
, vol.343
, pp. 246-253
-
-
Colucci, W.S.1
Elkayam, U.2
Horton, D.P.3
-
50
-
-
16344377117
-
Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure
-
Sackner-Bernstein JD, Skopicki HA, Aaronson KD. Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure. Circulation 2005;111:1487Y1491
-
(2005)
Circulation
, vol.111
, pp. 1487-1491
-
-
Sackner-Bernstein, J.D.1
Skopicki, H.A.2
Aaronson, K.D.3
-
51
-
-
79960090547
-
Effect of nesiritide in patients with acute decompensated heart failure
-
O'Connor CM, Starling, RC, Hernandez, AF, et al. Effect of nesiritide in patients with acute decompensated heart failure. N Engl J Med 2011; 365:32Y43
-
(2011)
N Engl J Med
, vol.365
, pp. 32-43
-
-
O'Connor, C.M.1
Starling, R.C.2
Hernandez, A.F.3
|